Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
CTOS 2016
Trabectedin or Gemcitabine-Taxotere in Relapsed Uterine Leiomyosarcoma (U-LMS)
CTOS 2016
Conference Correspondent
Read More ›
Phase 2 Study of Regorafenib in Patients with Metastatic STS (RESOUND)
CTOS 2016
Conference Correspondent
Read More ›
Adjuvant Therapies in Major Histological Subtypes of Extremity Soft-Tissue Sarcoma (STS)
CTOS 2016
Conference Correspondent
Read More ›
Alternate Dosing Regimen of Regorafenib in Gastrointestinal Stromal Tumors (GISTs)
CTOS 2016
Conference Correspondent
Read More ›
Outcomes of Older Patients with Osteosarcoma from the French Group Sarcoma (GSF-GETO)
CTOS 2016
Conference Correspondent
Read More ›
Trabectedin Approved for Use in Uterine Leiomyosarcoma
CTOS 2016
Conference Correspondent
In this interview, Martee Hensley, MD, a medical oncologist practicing at Memorial Sloan Kettering Cancer Center, commented on the introduction of trabectedin as a treatment alternative for women with uterine leiomyosarcoma.
Read More ›
Page 2 of 2
1
2